These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12154404)

  • 21. The epigenome of testicular germ cell tumors.
    Lind GE; Skotheim RI; Lothe RA
    APMIS; 2007 Oct; 115(10):1147-60. PubMed ID: 18042148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restriction landmark genomic scanning method and its various applications.
    Hayashizaki Y; Hirotsune S; Okazaki Y; Hatada I; Shibata H; Kawai J; Hirose K; Watanabe S; Fushiki S; Wada S
    Electrophoresis; 1993 Apr; 14(4):251-8. PubMed ID: 8388788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide profiling of promoter methylation in human.
    Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
    Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
    Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD
    Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of CpG islands of trophoblast giant cells by restriction landmark genomic scanning.
    Ohgane J; Aikawa J; Ogura A; Hattori N; Ogawa T; Shiota K
    Dev Genet; 1998; 22(2):132-40. PubMed ID: 9581285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
    Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
    Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restriction landmark genome scanning.
    Okuizumi H; Takamiya T; Okazaki Y; Hayashizaki Y
    Methods Mol Biol; 2011; 791():101-12. PubMed ID: 21913074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restriction landmark genome scanning.
    Costello JF; Plass C; Cavenee WK
    Methods Mol Biol; 2002; 200():53-70. PubMed ID: 11951655
    [No Abstract]   [Full Text] [Related]  

  • 29. DNAinsight: a web based image processing system for large scale RLGS analysis.
    Takahashi K; Nakazawa M; Watanabe Y
    Genome Inform; 2001; 12():212-21. PubMed ID: 11791240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restriction landmark genomic scanning.
    Ando Y; Hayashizaki Y
    Nat Protoc; 2006; 1(6):2774-83. PubMed ID: 17406534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
    Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
    Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of genetic alterations in the human gastric cancer cell lines by two-dimensional analysis of genomic DNA.
    Kim YS; Yoo HS; Lee KT; Goh SH; Jung JS; Oh SW; Baba M; Yasuda T; Matsubara K; Nagai H
    Int J Oncol; 2000 Aug; 17(2):297-308. PubMed ID: 10891539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations.
    Smiraglia DJ; Kazhiyur-Mannar R; Oakes CC; Wu YZ; Liang P; Ansari T; Su J; Rush LJ; Smith LT; Yu L; Liu C; Dai Z; Chen SS; Wang SH; Costello J; Ioshikhes I; Dawson DW; Hong JS; Teitell MA; Szafranek A; Camoriano M; Song F; Elliott R; Held W; Trasler JM; Plass C; Wenger R
    BMC Genomics; 2007 Nov; 8():446. PubMed ID: 18053125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
    Bastian PJ; Yegnasubramanian S; Palapattu GS; Rogers CG; Lin X; De Marzo AM; Nelson WG
    Eur Urol; 2004 Dec; 46(6):698-708. PubMed ID: 15548435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyl group acceptance assay for the determination of global DNA methylation levels.
    Nephew KP; Balch C; Skalnik DG
    Methods Mol Biol; 2009; 507():35-41. PubMed ID: 18987804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.